PHARMAP 2026 addresses this transformation with a specialised session on patient-friendly design and its role in modern ...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas. Built from ...

Sanofi has announced a change of leadership, with former Merck KGaA chief executive Belén Garijo taking the helm of the ...

Madrigal Pharma was the first drugmaker to bring a treatment for metabolic dysfunction-associated steatohepatitis (MASH) to ...

Novo Nordisk has been criticised by the FDA for a TV advertisement for its recently launched Wegovy pill, which the agency ...

According to Moderna, which used a valuable priority review voucher to speed up the FDA's review, the agency has said that ...

Cary Claiborne, CEO of Adial Pharmaceuticals, believes his company’s bet on a precision treatment for AUD, for patients with ...

Streeting announced the plan to allow NHS England to put the processes in place to share primary care data with scientific ...

In understanding what makes the patient voice so essential to successful drug development, let’s take a critical eye to what ...

Hunter syndrome, also known as mucopolysaccharidosis type II (MPS II), is a rare, X-linked recessive genetic disease caused ...

Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive ...

The 466,000 sq ft centre will serve as a hub to join Novartis' current R&D sites in Cambridge, Massachusetts, and Basel, ...